GENEREX BIOTECHNOLOGY CORP 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Oct 8, 2014
Insider Transaction Report
Form 4
FLETCHER MARK
EVP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2014-10-06$0.00/sh+470,726$471→ 470,726 total - Exercise/Conversion
Common Stock Purchase Option (Right to Buy)
2014-10-06−470,726→ 0 totalExercise: $0.00From: 2005-04-05Exp: 2014-10-26→ Common Stock (470,726 underlying)